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A custom built 1310 nm center wavelength swept source optical coherence tomography instrument was used to measure mor-
phological changes in treated and newly diagnosed untreated glaucomatous human Schlemm’s canal (SC). Thirty-seven pri-
mary open-angle glaucoma patients were divided into two groups depending on the patients having been treated or not. The 
statistical results showed that there were significant differences between the treated and untreated groups’ SC areas (treated, 
7935.6875±680.003 μm2; untreated, 3890.71875±871.49844 μm2; P<0.001), the circumferences (treated, 580.37891±44.96529 μm; 
untreated, 381.9026±41.22123 μm; P<0.001), and the long diameters (treated, 272.87806±25.7254 μm; untreated, 185.24047± 
19.72786 μm; P<0.001). We hypothesize that, after drug treatment, the SC will expand and the morphometric values especially 
the areas will become larger, thus helping to reduce intraocular pressure. 
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The World Health Organization predicts that 44.7 million 
people will suffer from primary open-angle glaucoma 
(POAG) [1]. Abnormally high intraocular pressure (IOP) is 
related to the development of glaucoma [2,3]. Comparative 
anatomy results suggest that the Schlemm’s canal (SC), 
which connects the trabecular meshwork and collector ca-
nals, is a possible resistance point of aqueous humor out-
flow in primary open angle glaucomatous eyes. This might 
explain the approximately 50% decrease of aqueous outflow 
facility in these patients [4]. The collapse of the SC at high-
er IOP might be a cause of POAG [5,6]. Therefore, meas-
uring the SC morphometric values quantitatively could pro-
vide important information for glaucoma diagnosis and 
treatment. However, the required resolution is in ten mi-
crometers range. Previous studies were therefore limited to 
histologic sections of animal eyes [46]. 
With increased revolution in frame rate and sensitivity, in 
the last few years, optical coherence tomography has been 
successfully used for SC imaging in vivo [710]. Kagemann 
et al. [7] measured the size of SC in one glaucoma patient 
using 870 nm spectral domain optical coherence tomogra-
phy (SD-OCT). SC morphometric values of 50 POAG pa-
tients were measured by swept source optical coherence 
tomography (SS-OCT) [8]. Consistent with the in vitro 
studies, the POAG eyes had significantly smaller SC areas 
compared with those of normal eyes [9]. In normal eyes, age 
and gender related SC areas have also been determined [10]. 
Further studies will suggest more uses for SS-OCT in this 
field. The comparison of different drug treatments in pa-
tients with POAG has previously been evaluated by the de-
crease of IOP [11,12]. Recent ex vivo studies show that IOP 
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is also related to SC morphology [13]. Therefore, although 
the SC may not be a criterion for POAG, it may be used to 
demonstrate if the SC morphology changes with drug 
treatment. Thus, it could provide a new approach to drug 
efficacy evaluation. 
In this report, a custom built 1310 nm SS-OCT instru-
ment was designed to demonstrate that SC morphology 
changes with drug treatment. High speed, high resolution 
imaging of the ocular anterior segment was achieved in vivo, 
and statistical analysis based on the high resolution SC im-
age was used to verify if the SC morphology was related to 
drug treatment.  
1  Materials and methods  
1.1  Swept source optical coherence tomography system 
As shown in Figure 1A and B, light from the swept source 
is divided by a fiber coupler to the Mach-Zehnder interfer-
ometer (5% optical power) and the Michelson interferome-
ter (95% optical power). The interference signal is received 
by the Michelson interferometer [9]. After calibrating the 
wave number of the interference signal by the Mach- 
Zehnder interferometer (INT-MZI-1300, Thorlabs, Newton, 
NJ 07860, USA), the actual axial resolution was 8.03 μm in 
the air, and 6 μm in an aqueous solution, measured by as-
suming the refractive index of water as 1.34. By using the 
GPU (Graphic Processing Unit) to process the data [14], the  
 
 
Figure 1  The custom built SS-OCT system. A, Schematic of SS-OCT 
system. B, A picture of the SS-OCT system during measurements. SS, 
swept laser source; C1, fiber coupler (5/95); C2C5, fiber coupler (50/50); 
BD, balance detector; PD, photo diode; LD, laser diode; WDM, wave-
length division multiplexer; C, circulator; PC, polarization controller; CL, 
collimator; ND, neutral density filters; M, mirror; SC, x-y scanner; Ob, 
objective; Bs, beam splitter; f-, f- scanner lens; TG, target; MZI, Mach- 
Zehnder interferometer; MSI, Michelson interferometer. 
system frame rate was 22.5 fps in real time. A 660 nm laser 
diode functioned as the aiming laser.  
A gantry structure was adapted to allow the subject to lie 
down during imaging, and positioned each individual sub-
ject approximately the same incidence beam angle. To en-
sure the scanning plane (B-scan) was orthogonal to the SC 
orientation, a three-dimensional electric translation stage, 
which could be controlled manually by a frontal control 
panel, was mounted on a sample arm to adjust the imaging 
location and focusing position. Table 1 shows the detailed 
specifications of this SS-OCT system. 
1.2  Subjects 
All subjects were recruited from POAG patients who visited 
the Eye Ear Nose and Throat Hospital (Fudan University, 
Shanghai, China). The study was conducted in accordance 
with the tenets of Declaration of Helsinki, and approved by 
the Ethics Committee of the Eye Ear Nose and Throat Hos-
pital, Fudan University. Each subject has signed an in-
formed consent agreement. Three common drugs, including 
timolol, latanoprost and dorzolamide, were used to treat the 
patients. Timolol and latanoprost can reduce the production 
of aqueous humor, while dorzolamide improves the outflow 
of aqueous humor. Because of the limitations of ethics ap-
proval requirements, we compared the morphological alter-
ations between treated and untreated glaucomatous human 
SC, but an efficacy evaluation of different drug treatments 
was not done. The incident light power (<1.5 mW) of the 
eye was lower than the maximum allowable exposure, 
which was safe for the retina. Before the experiments, every 
patient underwent a complete ophthalmic examination, in-
cluding IOP determinations (Goldman T900, HAAG- 
STREIT Diagnostics, Koeniz, Switzerland) and visual field 
examinations (VF, Humphrey, Kalamazoo Township, MI 
49048, USA). Subjects were divided into two groups as 
follows: the untreated group, with newly diagnosed, un-
treated POAG patients, and treated group, with patients 
whose conditions were controlled. 
Table 1  SS-OCT specifications 
System parameter Performance 
Center wave length 1310 nm 
3 dB bandwidth 110 nm 
Aiming laser 660 nm 
Axial resolution 8.03 μm in the air, 6 μm in aqueous solution 
A scan rate 20 kHz 
Cross-section image format 800 A-lines×512 pixel 
Frame rate 22.5 fps 
Scan range 
Depth: 2.97 mm in the air 
Transverse: 4.8 mm in the air for 800 
A-lines 
Pixel axial resolution 
depth：5.76 μm in the air; 4.3 μm in aqueous 
solution 
transverse: 6 μm in the air 
Power on eye <1.5 mW 
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All patients in the POAG group were bilateral, and a total 
of 37 participants were involved in the study, 19 in the 
treated group including 12 men (63%) and 7 (37%) women, 
from 20 to 74 years of age (average age, 53.3±18.3 years). 
The IOPs ranged from 12 to 19 mmHg (average, 15.5±1.8 
mmHg). The untreated group included 18 patients, 8 men 
(44%) and 10 (56%) women, from 19 to 77 years of age 
(average, 49.6±18.5 years), with IOPs from 21 to 29 mmHg 
(average, 23.6±2.1 mmHg). There was no significant dif-
ference in the distribution of age (P=0.47) and gender 
(P=0.28) between these two groups. The IOPs of the un-
treated group were higher than those of the control group. 
1.3  Quantitative analysis 
The cross-sectional images of the anterior chamber angle 
were taken with our SS-OCT system, including the cornea, 
iris, scleral spur, trabecular meshwork, and the SC, which is 
shown in Figure 2A. While performing the measurements, 
we manually magnified in image and designated the area of 
the SC. The diameter was then measured by the farthest 
distance of the two pixels, and the circumference was de-
termined by taking the sum of the distances. The area was 
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where xi and yi were the pixels’ coordinates, dx and dy were 
the lengths that each pixel represented in transverse and 
axial planes. Note that, yi was the pixel axial resolution in 
aqueous solution, which was 4.3 μm. 
Figure 2B is an image from a 45-year-old female patient 
whose condition was controlled by drugs. Figure 2C is an 
image from a 47-year-old female patient who had just been 
diagnosed with POAG. The morphological differences of 
the SCs between treated and untreated eyes can be observed  
 
 
Figure 2   The cross-sectional images from SS-OCT. A, The SS-OCT 
image of the anterior segment in a treated eye. B, The 4× image of a rec-
tangular region in (A). C, The 4× image from an untreated eye. SC, 
Schlemm’s canal; SL, Schwalbe’s line; TM, trabecular mesh; SS, scleral 
spur. 
from the images, and the detailed analysis is discussed be-
low. 
2  Results 
While in the supine, all participants were examined, by a 
single examiner. The anterior segment angle scan protocol 
was used for scanning the angle at the 3 and 9 o’clock posi-
tions, and each image contained 800 A-lines. Each position 
was imaged twice, and the images were stored for further 
analysis. 
The morphometric SC values were measured and de-
scribed as oculus dexter nasal (ODN), oculus dexter tem-
poral (ODT), oculus sinister nasal (OSN) and oculus sinister 
temporal (OST). The anterior chamber angles of all 74 eyes 
were imaged, and the cross-sectional images showed the 
cornea, iris, scleral spur, trabecular meshwork and the SC. 
The values for the subjects including the long diameter, 
circumference, and area of the SC in treated and untreated 
eyes are shown in Figure 3. Five eyes could not be imaged, 
including two untreated eyes and three treated eyes. The 
success rate of imaging the SC was approximately 86.5% 
(in 128 of the 148 scans).  
Statistical results were analyzed using Origin 19.0 (SPSS, 
IBM Inc., Chicago, Illinois, USA) to determine possible 
difference between the treated and untreated groups. A 
P-value less than 0.05 was considered statistically signifi-
cant. The normal distribution was expressed as mean± 
standard deviation (SD).  
The statistical values of long diameters, circumferences, 
and cross-section areas of the SCs in treated and untreated 
eyes are shown in Table 2. Date shown in Figure 3 demon-
strated that the untreated group had the smallest morpho-
metric values, particularly in the area of the SC. The corre-
sponding statistical analysis demonstrated that the long di-
ameters, circumferences, and areas of SCs in the treated 
group were larger than those in the untreated group, and the 
differences between the two groups were significant (Plong 
diameter<0.001; Pcircumference<0.001; Parea<0.001). 
Table 2  Statistical results of SC morphometric values 
 Mean SD 
Treated 
Long diameter (μm) 272.87806 25.7254 
Circumference (μm) 580.37891 44.96529 
Cross-section area 
(μm2) 7935.6875 680.0036 
Untreated 
Long diameter (μm) 185.24047 19.72786 
Circumference (μm) 381.9026 41.22123 
Cross-section area 
(μm2) 3890.71875 871.49844 
P-value Plong diameter<0.001 Pcircumference<0.001 Parea<0.001 
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Figure 3  The biological parameters of SCs in treated and untreated subjects. A, The distribution of the treated group. B, The distribution of the untreated 
group. The “average” means the average value of the OD and OS parameters, including the temporal and the nasal sides. 
3  Discussion 
High IOP is considered to be the most important risk factor 
for development of POAG, and its reduction continues to be 
the only successful way of treating the disease. The SC 
morphology is related to the aqueous outflow facility which 
regulates the IOP. Therefore, the change in SC morphology 
may be another parameter to assess the effects of drug 
treatment.  
The objective of this study was to determine whether the 
SC morphometric values were changed with drug treatment. 
By using SS-OCT, the anterior chamber angle was imaged 
at high resolution, and SC could be recognized in these 
OCT imaging. The successful imaging rate was about 
86.5% in a living human eye. The biological morphometric 
parameters of SC could be assessed properly, but because of 
subject movement from breathing and from eye movement, 
it was impossible to maintain the scanning plane (B-scan) 
perpendicular to the SC orientation in a living human eye. 
In the future, we will add a pupil camera to the SS-OCT 
system and improve the imaging speed to obtain real time 
three-dimensional image of SCs. 
Three commonly used drugs, timolol, latanoprost, and 
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dorzolamide, have been used to treat POAG patients. Tim-
olol and latanoprost reduced the production of aqueous hu-
mor, and dorzolamide improved the outflow of the aqueous 
humor. Though these drugs have different effects, the com-
parison experiments of drug treatments showed that these 
drugs could decrease the IOP [12,13].  
Although the exact mechanism of POAG is still unclear, 
the statistical analysis showed that the area, circumference, 
and long diameter of the SC were smaller in untreated pa-
tients than in the treated patients. The data suggested that 
the SC became wider with low IOP, and collapsed when the 
IOP increased [5]. As Table 2 shows, after drug treatment, 
the mean cross-sectional area more than doubled. Thus, it is 
reasonable to deduce that, after drug therapy, the IOP would 
be reduced, which would lead to the expansion of the SC, 
causing the area and circumference to become larger. The 
larger SC may increase the aqueous drainage in POAG pa-
tients and could lead to a further reduction of IOP.  
The use of OCT provides a non-invasive and new pro-
cedure in POAG pathogenesis research, which could facili-
tate the discovery of more effective and suitable methods to 
treat this disease. The statistical results obtained by the 
SS-OCT demonstrated that SC area may be an important 
index for POAG drug treatment efficacy. Although the size 
of the SC cannot be a criterion of POAG, it could provide a 
method to determine morphological changes in the SC with 
drug treatment. In our studies, widely used ocular hypoten-
sive drugs including timolol, latanoprost, and dorzolamide 
were used to treat POAG patients. These three drugs have 
different mechanisms of action. Currently, the ethics ap-
proval of this research allowed us only to measure the mor-
phological alterations of the glaucomatous human SC. Drug 
efficacy studies were therefore not done. The study was also 
limited by its small sample size, which is insufficient for a 
study of the effects of different treatment. In the future, we 
will recruit lager patient pool to investigate the effects of 
different treatment. 
4  Conclusion 
We found that the SC can be non-invasively imaged and 
measured in the living human eye by use of SS-OCT. The 
morphometric measurements of SCs were successfully per-
formed, showing that after drug treatment, patients had 
larger SC morphometric values. This could explain the IOP 
reduction in the control eyes. These studies provide another 
perspective for in vivo glaucoma research. In the future, we 
hope to analyze correlations between the IOP and SC mor- 
phometric values in a larger group of eyes treated with dif-
ferent drugs.  
This work was supported by the Sichuan Youth Science & Technology 
Foundation (2013JQ0028), the National Natural Science Foundation of 
China (61108082), the West Light Foundation of the Chinese Academy of 
Sciences, and the National Major Scientific Equipment Program 
(2012YQ120080). 
1 Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet, 2004, 
363: 1711–1720 
2 Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, 
Singh K. Relationship between intraocular pressure and primary open 
angle glaucoma among white and black Americans. The Baltimore 
Eye Survey. Arch Ophthalmol, 1991, 109: 1090–1095 
3 Bellezza AJ, Rintalan CJ, Thompson HW, Downs JC, Hart RT, Bur-
goyne CF. Deformation of the lamina cribrosa and anterior scleral 
canal wall in early experimental glaucoma. Invest Ophthalmol Vis 
Sci, 2003, 44: 623–637 
4 Allingham RR, de Kater AW, Ethier CR. Schlemm’s canal and pri-
mary open angle glaucoma: correlation between Schlemm’s canal 
dimensions and outflow facility. Exp Eye Res, 1996, 62: 101–109  
5 Hulzen RD, Johnsonl DH. Effect of fixation pressure on juxtacana-
licular tissue and Schlemm’s canal. Invest Ophthalmol Vis Sci, 1996, 
37: 114–124 
6 Nesterov AP. Role of the blockade of Schlemm’s canal in pathogene-
sis of primary open-angle glaucoma. Am J Ophthalmol, 1970, 70: 
691–696 
7 Kagemann L, Wollstein G, Ishikawa H, Bilonick RA, Brennen PM, 
Folio LS, Gabriele ML, Schuman JS. Identification and assessment of 
Schlemm’s canal by spectral domain optical coherence tomography. 
Invest Ophthalmol Vis Sci, 2010, 51: 4054–4059 
8 Shi GH, Wang F, Li XQ, Lu J, Ding ZH, Sun XH, Jiang CH, Zhang 
YD. Morphometric measurement of Schlemm’s canal in normal hu-
man eye using anterior segment swept source optical coherence to-
mography. J Biomed Opt, 2012, 17: 016016  
9 Wang F, Shi GH, Li XQ, Lu J, Ding ZH, Sun XH, Jiang CH, Zhang 
YD. Comparison of Schlemm’s canal’s biological parameters in pri-
mary open-angle glaucoma and normal human eyes with swept 
source optical coherence tomography. J Biomed Opt, 2012, 17: 
116008 
10 Shi GH, Wang F, Li XQ, Lu J, Sun XH, Jiang CH, Zhang YD. As-
sessment of Schlemm’s canal in a normal human eye by swept source 
optical coherence tomography. Laser Phys Lett, 2013, 10: 075602 
11 Orzalesi N, Rossetti L, Invernizzi T, Bottoli A, Autelitano A. Effect 
of timolol, latanoprost, and dorzolamide on circadian IOP in glauco-
ma or ocular hypertension. Invest Ophthalmol Vis Sci, 2000, 41: 
2566–2573  
12 Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, 
Gandolfo E. Effects of topical hypotensive drugs on circadian IOP, 
blood pressure, and calculated diastolic ocular perfusion pressure in 
patients with glaucoma. Invest Ophthalmol Vis Sci, 2006, 47: 
2917–2923  
13 Li P, Reif R, Zhi ZW, An L, Martin E, Shen T, Johnstone M, Wang 
RK. Phase-sensitive optical coherence tomography characterization 
of pulse-induced trabecular meshwork displacement in ex vivo 
non-human primate eyes. J Biomed Opt, 2012, 17: 076026 
14 Li XQ, Shi GH, Zhang YD. Time domain interpolation on graphics 
processing unit. J Innovat Opt Health Sci, 2011, 4: 89–95 
 
Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction 
in any medium, provided the original author(s) and source are credited. 
